tetano
Editor, Senior Moderator
Emerg Infect Dis
. 2020 Dec 8;27(3).
doi: 10.3201/eid2703.202284. Online ahead of print.
COVID-19-Associated Fusobacterium nucleatum Bacteremia, Belgium
Louis Wolff, Delphine Martiny, V?ronique Yvette Miendje Deyi, Evelyne Maillart, Philippe Clevenbergh, Nicolas Dauby
Abstract
We report 4 cases of Fusobacterium nucleatum bacteremia associated with coronavirus disease (COVID-19). Three cases occurred concomitantly with COVID-19 diagnosis; 1 occurred on day 15 of intensive care. None of the patients had known risk factors for F. nucleatum bacteremia. F. nucleatum infection could represent a possible complication of COVID-19.
Keywords: COVID-19; Fusobacterium nucleatum; SARS; SARS-CoV-2; bacteremia; bacteria; coronavirus; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; tocilizumab; viruses; zoonoses.
. 2020 Dec 8;27(3).
doi: 10.3201/eid2703.202284. Online ahead of print.
COVID-19-Associated Fusobacterium nucleatum Bacteremia, Belgium
Louis Wolff, Delphine Martiny, V?ronique Yvette Miendje Deyi, Evelyne Maillart, Philippe Clevenbergh, Nicolas Dauby
- PMID: 33292922
- DOI: 10.3201/eid2703.202284
Abstract
We report 4 cases of Fusobacterium nucleatum bacteremia associated with coronavirus disease (COVID-19). Three cases occurred concomitantly with COVID-19 diagnosis; 1 occurred on day 15 of intensive care. None of the patients had known risk factors for F. nucleatum bacteremia. F. nucleatum infection could represent a possible complication of COVID-19.
Keywords: COVID-19; Fusobacterium nucleatum; SARS; SARS-CoV-2; bacteremia; bacteria; coronavirus; coronavirus disease; respiratory infections; severe acute respiratory syndrome coronavirus 2; tocilizumab; viruses; zoonoses.